Lans Holdings Inc (OTCMKTS: LAHO) has been on an explosive rise over the past few weeks after the Company announced a binding LOI to acquire 100% of Global Stem Cells Group Inc. (GSCG) an emerging operator in the booming global stem cell market.
LAHO has transformed into a volume leader in recent weeks seeing an explosive rise from a start point in the low triple z’s and recent highs of $0.0017. With a significant dip taking place traders are loading up for another run.
Lans Holdings Inc (OTCMKTS: LAHO) describes itself as a provider of white label solutions for commerce and communication service providers to enable business to consumer and business to business secure transactions through physical point-of-sale, mobile devices, online and software integrations. We are focused to provide reliable, secure solutions that motivate and reward our partners to “migrate to the cloud” using our cost-effective infrastructure, platforms and services. MISSION – To Create a Competitive Advantage for our Customers by Improving Security, Revenue, and Scalability VISION – Be the TECH Leader in Solutions for Secure Transaction Platforms by Providing Breakthrough Technology
On May 28 LAHO announced it has entered into a binding letter of intent to acquire 100% of Global Stem Cells Group Inc. (GSCG). GSCG operates in the global stem cell market which is forecasted by Transparency Market Research to reach $270 billion dollars by 2025 of which roughly 40% or $100 billion will be derived from outside of North America and growing at a 13.8% compounded annual growth rate.
GSCG specializes in leading-edge stem cell research, patient application and physician training. The company licenses its name and intellectual property to physicians around the world and supplies them with necessary equipment and medical supplies to perform stem cell treatments. The company currently has one of the largest member clinic networks in the world spanning over 25 countries.
To Find out the inside Scoop on LAHO Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
Dave Christensen, CEO of Lans Holdings Inc. stated:
“We are very pleased to have entered into this binding LOI with Global Stem Cells Group. This transaction represents a significant opportunity for our company to enter the explosive field of Stem Cell technology with a proven and seasoned team and I look forward to working closely with GSCG to execute on their growth plans.”
Benito Novas, President and CEO of Global Stem Cells Group stated:
“We are excited to join forces with Lans Holdings. This union will allow us to have access to the capital markets to further fuel our growth as the global stem cells market enters into an accelerated expansion phase.”
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $1.2 million market valuation LAHO has little assets or revenues and over $8 million in liabilities which could lead to massive dilution. However, as many investors have noted the Company will have a hard time affecting a RS and noteholders will have a hard time converting debt into paper as long as LAHO has the stop sign designation. LAHO is an exciting story in small caps; the global stem cell market is booming and is forecasted by Transparency Market Research to reach $270 billion dollars by 2025 and according to the Company it licenses its name and intellectual property to physicians around the world and supplies them with necessary equipment and medical supplies to perform stem cell treatments. The company currently has one of the largest member clinic networks in the world spanning over 25 countries. We will be updating on LAHO when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with LAHO.
Sign Up now for our 100% FREE Penny Stock Newsletter
Disclosure: we hold no position in LAHO either long or short and we have not been compensated for this article.